Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis
暂无分享,去创建一个
M. De Vos | G. Verbruggen | D. Elewaut | F. de Keyser | H. Mielants | P. Jacques | E. Kruithof | B. Vandooren | L. Melis
[1] D. D’Lima,et al. Rho kinase-dependent CCL20 induced by dynamic compression of human chondrocytes. , 2008, Arthritis and rheumatism.
[2] S. Chevalier,et al. Chronically Inflamed Human Tissues Are Infiltrated by Highly Differentiated Th17 Lymphocytes , 2008, The Journal of Immunology.
[3] L. Wedderburn,et al. Interleukin-17–producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers , 2008, Arthritis and rheumatism.
[4] Lisa C. Zaba,et al. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses , 2007, The Journal of experimental medicine.
[5] Hiromu Ito,et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model , 2007, The Journal of experimental medicine.
[6] Y. Obata,et al. A Proximal κB Site in the IL-23 p19 Promoter Is Responsible for RelA- and c-Rel-Dependent Transcription , 2007, The Journal of Immunology.
[7] Simon C. Potter,et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants , 2007, Nature Genetics.
[8] D. Hommes,et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. , 2007, Immunity.
[9] Kathleen M. Smith,et al. Development, cytokine profile and function of human interleukin 17–producing helper T cells , 2007, Nature Immunology.
[10] L. Cosmi,et al. Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.
[11] A. Nagano,et al. Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis , 2007, Rheumatology International.
[12] Simon C. Potter,et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.
[13] D. Jarrossay,et al. Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells , 2007, Nature Immunology.
[14] J. Ruland,et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17 , 2007, Nature Immunology.
[15] R. Nussenblatt,et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 , 2007, Nature Medicine.
[16] D. Wendling,et al. Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis. , 2007, Joint, bone, spine : revue du rhumatisme.
[17] R. D. Hatton,et al. IL-17 family cytokines and the expanding diversity of effector T cell lineages. , 2007, Annual review of immunology.
[18] M. Lebwohl,et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. , 2007, The New England journal of medicine.
[19] P. Valdez,et al. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis , 2007, Nature.
[20] Steven J. Schrodi,et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. , 2007, American journal of human genetics.
[21] Judy H. Cho,et al. A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.
[22] Dafna Gladman,et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. , 2006, Arthritis and rheumatism.
[23] M. Breban. Genetics of spondyloarthritis. , 2006, Best practice & research. Clinical rheumatology.
[24] L. Joosten,et al. Interleukin-17 Acts Independently of TNF-α under Arthritic Conditions1 , 2006, The Journal of Immunology.
[25] T. Mcclanahan,et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. , 2006, The Journal of clinical investigation.
[26] L. Joosten,et al. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. , 2005, The American journal of pathology.
[27] M. Neurath,et al. Anti-interleukin-12 antibody for active Crohn's disease. , 2004, The New England journal of medicine.
[28] D. Baeten,et al. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy. , 2004, Arthritis and rheumatism.
[29] T. Mcclanahan,et al. Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation , 2003, The Journal of experimental medicine.
[30] Pawan Kumar,et al. Role of Macrophage Inflammatory Protein-3α and Its Ligand CCR6 in Rheumatoid Arthritis , 2003, Laboratory Investigation.
[31] S. Ferretti,et al. IL-17, Produced by Lymphocytes and Neutrophils, Is Necessary for Lipopolysaccharide-Induced Airway Neutrophilia: IL-15 as a Possible Trigger , 2003, The Journal of Immunology.
[32] A. Gurney,et al. Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17* , 2003, The Journal of Biological Chemistry.
[33] J. Shellito,et al. Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense , 2001, The Journal of experimental medicine.
[34] L. Joosten,et al. IL-1-Independent Role of IL-17 in Synovial Inflammation and Joint Destruction During Collagen-Induced Arthritis1 , 2001, The Journal of Immunology.
[35] T. Matsui,et al. Selective recruitment of CCR6‐expressing cells by increased production of MIP‐3α in rheumatoid arthritis , 2001, Clinical and experimental immunology.
[36] J Wagner,et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. , 2000, Immunity.
[37] A. Foussat,et al. Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3alpha/CCL20 in human B cells. , 2000, Blood.
[38] J. Lötvall,et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. , 1999, Journal of immunology.
[39] C. Caux,et al. Selective Recruitment of Immature and Mature Dendritic Cells by Distinct Chemokines Expressed in Different Anatomic Sites , 1998, The Journal of experimental medicine.
[40] P. Miossec,et al. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. , 1998, Journal of immunology.
[41] H. Nomiyama,et al. Identification of CCR6, the Specific Receptor for a Novel Lymphocyte-directed CC Chemokine LARC* , 1997, The Journal of Biological Chemistry.
[42] M. Dougados,et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. , 1991, Arthritis and rheumatism.
[43] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[44] D. Goldenberg,et al. SYNOVIAL MEMBRANE HISTOPATHOLOGY IN THE DIFFERENTIAL DIAGNOSIS OF RHEUMATOID ARTHRITIS, GOUT, PSEUDOGOUT, SYSTEMIC LUPUS ERYTHEMATOSUS, INFECTIOUS ARTHRITIS AND DEGENERATIVE JOINT DISEASE , 1978, Medicine.
[45] B. Thiers. A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk Genes , 2008 .
[46] C. Eun. A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene. , 2007 .
[47] F. Padova,et al. Interleukin-17 Acts Independently of TNF- , 2006 .
[48] D. Elewaut,et al. Needle Arthroscopy of the Knee with Synovial Biopsy Sampling: Technical Experience in 150 Patients , 1999, Clinical Rheumatology.